A Comparative study of active management of third stage labor with conventional method in prevention of PPH in at risk mothers by Anuradha, J
A COMPARATIVE STUDY OF ACTIVE MANAGEMENT OF 
THIRD STAGE LABOR WITH CONVENTIONAL METHOD 
IN PREVENTION OF PPH IN AT RISK MOTHERS 
 
 
 
Dissertation Submitted to 
THE TAMIL NADU DR.MG.R. MEDICAL UNIVERSITY 
 
 
 
In partial fulfillment of the 
regulations 
for the award of the degree of 
 
M.D (BRANCH – II) 
OBSTETRICS AND GYNAECOLOGY 
 
 
 
 
 
 
 
 
 
 
 
 
 
MADRAS MEDICAL COLLEGE 
CHENNAI 
 
MARCH   2008 
 CERTIFICATE 
 
Certified that this dissertation entitled "A COMPARATIVE STUDY OF 
ACTIVE MANAGEMENT OF THIRD STAGE LABOR WITH 
CONVENTIONAL METHOD IN PREVENTION OF PPH IN AT RISK 
MOTHERS" is  a  bonafide  work done by Dr. J. ANURADHA, M.D., Post 
Graduate Student of OBSTETRICS AND GYNAECOLOGY, under my overall 
supervision and guidance at the Institute of social Obstetrics and Government 
Kasturba Gandhi Hospital for Women and Children, Madras Medical College and 
Research Institute, Chennai, in partial fulfillment of regulations of Tamilnadu Dr. 
M.G.R. Medical University for the award of M.D degree in Obstetrics and 
Gynaecology during the academic  year 2005 - 2008.  
 
      Prof. Dr.VASANTHA.N.SUBBIAH  
         M.D.,D.G.O., 
      Director 
      Institute of social obstetrics and 
      Government Kasturba Gandhi hospital 
      For Women and Children 
      Madras Medical College  
      Chennai 
           
Prof. Dr. K.SARASWATHI  
 M.D., DGO.,    
Director,  
Institute of Obstetrics and Gynaecology  
  Madras Medical College  
  Chennai. 
 
 
Prof .Dr.T.P. KALANITI, M.D., 
Dean, 
Madras Medical College 
Chennai. 
ACKNOWLEDGEMENT 
 My sincere thanks to Prof. Dr. T. P. KALANITI, M. D., the Dean, 
Madras Medical College for allowing me to do this dissertation and utilize 
the institutional facilities. 
 I would like to express my sincere gratitude to Prof. 
Dr.VASANTHA. N. SUBBIAH., MD., DGO. Professor of Obstetrics and 
Gynaecology, Director, Institute of Social Obstetrics and Government 
Kasturba Gandhi Hospital for Women and Children for her valuable 
guidance and support in doing this study. 
 I would like to thank Prof. Dr.K.SARASWATHI M.D., D.G.O., 
Director, Institute of Obstetrics and Gynaecology for permitting me to 
undertake this study. 
 I am extremely thankful to Dr.S.RATHNA KUMAR, M.D., 
D.G.O., Reader, Department of Obstetrics and Gynaecology, Institute of 
Social Obstetrics and Government Kasturba Gandhi Hospital, Chennai for 
his guidance, invaluable help, encouragement and support throughout the 
study. 
 I sincerely thank Dr.C.SUGUMARI, M.D., D.G.O., Registrar, for 
her immense support and guidance in doing this study. 
 I am extremely thankful to all my professors and assistant professors 
for their encouragement and guidance. 
 I also thank all the staff members of labour ward who kindly 
contributed for the successful completion of this project. 
 I sincerely thank all the patients who have submitted themselves for 
this study, without whom this study would not have been possible. 
CONTENTS 
 
Sl. No. Title Page 
No. 
I INTRODUCTION 1 
II REVIEW OF LITERATURE 6 
III AIM OF THE STUDY 21 
IV MATERIALS AND METHODS 22 
V OBSERVATION 27 
VI DISCUSSION 45 
VII SUMMARY 58 
VIII CONCLUSION 60 
IX BIBLIOGRAPHY  
X PROFORMA  
XI MASTER CHART  
 
 
INTRODUCTION 
 The third stage of labor refers to the period following the delivery 
of the fetus to the delivery of placenta. 
 Relatively little thought or teaching seems to be devoted to the 
third stage of labor compared with that given to first & second stages. A 
leading North American obstetrics text devotes only 4 of more than 1500 
paper to third stage of labor but significantly more to the complications 
that may arise immediately following delivery (Cunningham, 2001)1. 
One author states, “This indeed is the unforgiving stage of labor 
and in it there lurks more unheralded treachery than in both the other 
stages combined. The normal case can, within a minute, become 
abnormal and successful delivery can turn swiftly to disaster” (Donald, 
1979)2. 
About 5.29 lakh mothers die in child birth every year in the world 
(WHO, 2004). Maternal mortality and morbidity is 50 times more 
common in developing countries than in developed countries (Kwast et 
al, 1986)3. According to WHO report 2004, maternal mortality ratio are 
shown as MMR per 1 lakh Live Birth. 
Region MMR No of  Maternal death 
World average 400 529000 
Developed Countries <20 2500 
Asia 330 253000 
Africa 830 251000 
Latin America 190 22000 
Oceana 240 530 
India 307 136000 
MMR in South East Asia 
Srilanka        30  
China        115  
Thailand        200 
Pakistan        340 
India        307  
Bangladesh   850 
With 16% of world’s population, India counts for over 20% of 
world’s maternal death. The maternal mortality ratio is incredibly high at 
307/100,000 LB which is unacceptable when, other health and economic 
indicators are showing an upward trend in India4. 
WORLD HEALTH REPORT 2005 
 ‘Make every mother & child count’ 
 ‘More than half a million women will die in pregnancy, childbirth 
or soon after that. Reducing the toll in line with the Millennium 
Development Goal depends largely on every mother having right to 
access to health care. 
 According to WHO 2005, contributors to maternal mortality ratio 
are 
PPH            25% 
Infection  13% 
Anemia  19% 
Eclampsia 12% 
Obstructed labor     8% 
Complication of abortion  13% 
Others                      9% 
PPH remains the most common cause of maternal death in 
developing countries. The condition has not changed for over a century. 
WHO statistics suggest that 25% of maternal deaths are due to PPH 
accounting for more than 100,000 maternal deaths per year 
(Abouzahr,1998)5. The death of these mothers has serious complications 
for the newborn and any other surviving children. 
There were nearly 1000 maternal deaths in Tamil Nadu in 2005-06 
with a MMR of 92/100,000 live births out of which nearly 35% is due to 
hemorrhage (National Family Health Survey III). 
Several complication encountered in the third stage of labor may 
lead to maternal morbidity. PPH leads to poor iron reserves, ultimately 
contributing to anemia. Anemia may cause weakness & fatigue. 
Hospitalization may be prolonged and establishment of breastfeeding 
may be affected. A blood transfusion may ameliorate the anemia and 
shorten the hospital stay, but it carries the risk of transfusion reaction and 
infection. Access to safe blood is not universal and PPH can sometimes 
strain the resources of the best blood bank. The primary aim in the 
management of PPH should be its prevention (Chamberlain 1992). 
Uterine atony remains the major cause of PPH. Adequate contraction & 
retraction of it is essential for prevention of PPH. 
Active management of third stage of labor  
(Reproductive Health Research, WHO, 2003)4 
1. administration of oxytocics within 1 min of baby’s birth 
2. controlled cord traction  with counter traction. 
3. Uterine massage. 
The Hinchingbrooke randomised controlled trial6, reported in 
Lancet in 1998, and concluded that PPH was significantly lower in active 
management compared to expectant management (6.8% Vs 16.5% 
respectively).  Bristol trial7 demonstrated significant reduction in 
incidence of PPH with active management as compared to expectant 
management (5.9% Vs 17.9%). 
Active management of 3rd stage of labor with prophylactic 
oxytocics, controlled cord traction and uterine message has made the III 
stage of labor less hazardous. Careful vigilance during the short interval 
between the delivery of baby and placenta will go a long way in 
decreasing retained placenta with its attendant risks. Though active 
management of labor has become a routine in most of the centers, in this 
part of country, 3rd stage of labor is still managed by conventional 
methods in many places unless the patient’s condition warrants 
prophylactic intervention. This preliminary study was undertaken to 
analyse the superiority or otherwise of active management of 3rd stage of 
labor Vis a Vis conventional method of giving IV methylergometrine 
after delivery of placenta. 
REVIEW OF LITERATURE 
The traditional conservative attitude to the management of third 
stage is changing. Recently, the decrease in the complication of third 
stage of labor has been attributed to wider judicious use of oxytocic 
preparations and a change from expectant conservatism to an intelligent 
active intervention. 
Brandt (1983)8 explained the mechanism of separation and 
expulsion of the placenta in detail. Brandt’s technique consisted of 
clamping the umbilical cord close to the vulva, immediately after the 
delivery of the infant. The uterus is palpated gently without massage to 
determine whether firm contractions are occurring. After several uterine 
contractions a change in size and shape of uterus indicates separation of 
placenta. Then the clamp at the vulva is held firmly with one hand and 
the finger tips of the other hand are placed on the abdomen and pressed 
between the fundus and symphysis pubis to elevate the fundus. On doing 
so, if placenta is separated the cord will extrude into the vagina. Further 
elevation of fundus and traction of cord deliver the placenta. 
Andrews (1940)10 working independently described a similar 
method of expulsion of placenta and obtained good results. Brews (1948) 
Gibbard (1955) allowed fundal pressure on the uterus as a method of 
assisting the delivery of separated placenta. Browne and Mccluse (1955) 
pointed out that Crede’s method can cause shock. 
The Brandt – Andrews technique was described by De-Lee, 
Greenhill (1947)32 and advocated because the Crede’s method has 
potential dangers. 
Norman Kimbell11 modified the technique. Instead of using a hand 
to grasp the umbilical cord he used forceps. The modified technique is as 
follows: A pair of forceps is placed on the umbilical cord as close to the 
vulva. One hand grasps the forceps and the other hand is placed on the 
abdomen. The uterus is gently pressed backwards and upwards towards 
umbilicus, at the same time steady traction given on the umbilical cord. 
Picton (1951) advocated Brandt Andrew’s technique for 
conducting the normal third stage. He advised IV Ergometrine with the 
birth of anterior shoulder. Those who have used Brandt-Andrews 
technique extensively and advocate its routine use are Dee-Lee (1947), 
Picton (1951), Kimbell (1958), Greenhill (1960), Clyne (1963), Brews 
(1963), Donald (1964), Hibbard (1964). Others favoring Brandt-Andrews 
method are Morris (1951), Elwin (1960), Frader and Tatford (1961), 
Shaw (1949), and Tritch and Schneider (1945). Naidu et al (1955) 
described Brandt-Andrews method as safe, simple and free from danger 
of inversion. 
Spencer (1962)12 has modified Brandt-Andrews method by 
combining it with an oxytocic given intravenously at the time of delivery 
of the anterior shoulder and replaced the term to controlled cord traction. 
Lister (1950)13 and Martin and Dumoulin (1955) established that 
intravenous ergometrine given with the birth of head or anterior shoulder 
reduces the risk of hemorrhage but has some disadvantages. The injection 
has to be precisely timed and it requires the presence of a second 
attendant at the time of delivery. Intramuscular ergometrine is less 
satisfactory mainly because it is slower in action (Embrey, 1961), but it 
has been advocated by Duly (1951) who reported a considerable 
improvement on physiological management of third stage. 
Kimbell (1954, 1958)11 added hyaluronidase to the intramuscular 
injection to speed up the action of ergometrine. He reported very good 
results and these were confirmed by Dutton (1958). 
Embrey and his collegues (1963)14, 15 have shown that a mixture of 
syntocinon and ergometrine acts more quickly than ergometrine and 
hyaluronidase and it is more effective when given by intramuscular 
injection. There seems to be tendency when ergometrine is given earlier, 
for the placenta to be retained either by generalised contraction or an 
hourglass contraction of uterus. In all reported series the manual removal 
of placenta is over 1%. Davis and Boynton (1942)17 met with retained 
placenta in 0.8% of cases which necessitated manual removal of placenta 
as Credes’s expression. Shaw (1949) did not find any significant 
difference between control and study cases after administration of 
ergometrine. Schade (1950) reported an insignificant percentage of 
complications. Bose (1955) reported retained placenta in 2.5 percent of 
his cases. Naidu (1955)18 also feels satisfied with the results of this drug 
as there was almost a complete absence of retained placenta. 
Methyl ergometrine (methergin) is a superior drug than 
ergometrine in reducing the duration of third stage as quoted by  Riordan 
(1950) and Cruden(1953).  Methyl ergometrine is one and half times 
stronger in its oxytocic effects than ergometrine (Gill, 1947). 
Leff(1952)  used synthetic preparations of oxytocin in combination 
with methyl  ergometrine  and a few have used it separately. In the whole 
series pitocin stands equally but in no way better than methyl 
ergometrine. 
Intravenous ergometrine acts in 45 seconds, intramuscular 
ergometrine in 7 minutes, and intramuscular ergometrine with hyalse 4 
minutes 47 seconds. Embrey found that after ergometrine, there was a 
well marked uterine spasm for 45 minutes, followed by evidence of 
contraction for 3 hours. 
Fleigner – JR (1978)19,20 compared the advantages and 
disadvantages of the traditional method versus the use of controlled cord 
traction. It is recommended that ergometrine (0.25mg) be administered 
intravenously after delivery of the baby and the exclusion of a second 
twin. 
Djahanhakhch and Vere (1978)21 recommend the intramuscular use 
of oxytocic agents for prophylactic management of the third stage of 
labor. Van-Coeverden (1982)22 introduced a revised scheme of 
management of third stage of labor. Patients received synthetic oxytocin 
5 IU intramuscularly with the delivery of the anterior shoulder and 
ergometrine maleate 0.5 mg intramuscularly after delivery of the 
placenta. In this study a significant decrease in the incidence of post 
partum hemorrhage and retained placenta was observed. 
Heinonen et al (1985)23 stressed upon the pharmacologic 
management and controlled cord traction in the third stage of labor. The 
work comprised of active management of the third stage of labor over a 
period of 15 years, consisted of intramuscularly administered 
combination of ergometrine(0.2 mg)  and oxytocin(5 units) and controlled 
cord traction as mechanical assistance in delivery of the placenta 
Thornton et al (1988)25 compared the natural and active 
management of third stage of labor and plasma oxytocin during third 
stage of labor. They have recommended routine administration of 
intramuscular oxytocin during the third stage 
Elbourne D(1988)26 stressed the fact that prophylactic use of 
oxytocics reduces the risk of post partum hemorrhage by about 40% 
based on the evidence from controlled trials. 
Candussi – G (1989)27 compared the use of oxytocin and 
ergometrine maleate and stated the usefulness of both drugs in the active 
management of the third stage of labor. 
Poeschman – RP28 et al made a randomized comparison of 
oxytocin, sulprostone and placebo in the management of the third stage of 
labor. The effects on post partum blood loss, following  prophylactic 
administration of oxytocin and sulprostone were compared. Postpartum 
blood loss was reduced almost equally by about 35% by both oxytocin 
and sulprostone.  Mean length of third stage was short in both groups 
receiving the active treatment.  
Prendiville et al., Harding  et al., in 19887 in the Bristol trial  
compared the efficacy of Active Management of Third stage Labor with 
Expectant Management. The rate of PPH was high in control than in 
Active Management of Third stage Labor even in low risk group (17.9% 
Vs 5.91%). Duration of third stage labor (15min in Expectant 
Management  Vs 5 min in Active Management of Third stage Labor), 
blood loss in third stage and need  for therapeutic oxytocics (2.9.7% Vs 
6.4% ) was also high.  
Rogers et al.,  Wood et al., (1998)6  in Hinchingbrooke RCT 
compared the rate of primary PPH and long term consequences between 
Active Management of Third stage Labor  and EMTL group, in  women 
at low risk for PPH. They found a significant reduction in the rate of PPH 
(6.8% in Active Management of Third stage Labor Vs 16.5 % in 
Expectant Management).  
Thilaganathan et al (1993) in U.K.30 compared Active Management 
of Third stage Labor Vs Expectant Management in low risk women. The 
duration of third stage was significantly longer in Physiological group.  
But there was no significant difference in estimated blood loss. 
The Cochrane systemic review (2000)29B identified 5 RCTs 
comparing Active Management of Third stage Labor with Expectant 
Management. Active Management was associated with a reduced risk of 
PPH and severe PPH, a shorter third stage, a reduced risk of anemia, a 
decreased need for blood transfusion and a decreased need for additional 
uterotonics.  It was associated with increased risk of maternal nausea, 
vomiting and elevated BP. 
David Chelmov et al, (2004)31 studied the efficacy of active 
management. IV oxytocics given after delivery of placenta were taken as 
control. Active management significantly reduced the risk of PPH, 
postpartum hemoglobin level, need for transfusion and additional 
medication. There was no significant difference in the need for manual 
removal of placenta. 
Joshua et al in 200534 showed that active management of third 
stage labor was effective in reducing the postpartum blood loss, and the 
rate of PPH in rural American Indian women. 
Tsu et al, Mai et al (2006)36 in Vietnam, studied the effectiveness 
of Active Management of Third stage Labor using Government 
midwives. Active Management of Third stage Labor was associated with 
reduced risk of prolonged third stage beyond  30 min, supplemental 
oxytocin and bimanual compression. Active Management of Third stage 
Labor was associated with 34% reduction of PPH. 
Maughan et al., in 200635 showed that Active Management of 
Third stage Labor provides a better balance of benefits and harm 
(evidence level A ) as compared to other  conventional  methods (giving 
uterotonics with delivery of anterior shoulder or  after  delivery of 
placenta, with  evidence level of B) 
Fullerton et al., Frick  et al., in 200637 in Guatemala and Zambia 
studied the net benefit of using Active Management of Third stage Labor 
rather than Expectant Management. A positive net benefit is from Active 
Management of Third stage Labor with a net saving of $18000 US in 
Guatemala (with 100 lives saved) & US $ 145000 in Zambia (with 467 
lives saved for 100000 births. 
                                THIRD STAGE OF LABOR 
Physiology of third stage of labor 
The 3rd stage of labor commences with delivery of the infant and 
ends with delivery of the placenta. Mean length is 6 minutes and the 97 th  
percentile is 30minutes. 
Physiological mechanism in the delivery of the placenta 
Uterine contractions continue after the birth of infant and 
intrauterine pressure continues to be rhythmically raised. After delivery 
of the infant the uterine muscle contract and retract with resultant 
shortening of the upper segment. This shortening reduces the area of the 
uterine surface to which the relatively incompressible placenta is 
attached. Separation of placenta occurs as a result of retraction and the 
consequent reduction in intra uterine volume tends to force the placenta 
in to the relaxed lower segment (Mac person & Wilson 1965). When the 
separation is complete, placenta is forced into the vagina and it may be 
delivered spontaneously by maternal efforts. 
The continued retraction of the uterine muscle is of paramount 
importance in minimizing the blood loss. The blood vessels supplying the 
placenta site are compressed by the oblique fibers of the middle layer of 
myometrium, “the living ligatures” (Basket, 1999)39.Blood flow through 
the placenta at term is 700 ml/mt. This has to be arrested within seconds 
following placenta separation otherwise serious hemorrhage will occur. 
Any factor that hinders uterine contraction and retraction, 
predisposes to hemorrhage. E.g. atony of uterus, due to antepartum 
hemorrhage, over distended uterus and prolonged labor. 
Mechanism of placental separation 
In Matthew Duncan method the lower edge of placenta present first 
at the vulva, there is marginal separation of placenta.                                
In Schultz method (more common) the placenta is delivered like an 
inverted umbrella the fetal surface appearing first with membrane 
covering the maternal surface. 
Signs of placental Separation 
(Sleep 1993, Cunningham 2001)1 
a) The most reliable sign is lengthening of the umbilical cord as 
the placenta separates & is pushed into the lower segment by 
progressive uterine retraction. 
b) The uterus becomes more globular and firmer. 
c) The uterus raises in the abdomen .The descent of placenta into 
lower segment and into vagina, displaces the uterus upward. 
d) The gush of blood occurs. 
Management of III stage of labor 
1. Expectant Management (Physiological) 
- awaiting the spontaneous separation of placenta, ensure that 
uterus is firmly contracted. 
- Mother is asked to bear down & placenta is delivered by gravity  
- Oxytocics are not used or used after delivery of placenta. 
-  If placenta is not delivered spontaneously, wait and try putting 
baby to breast & encourage maternal effort.  
- Measures such as nipple stimulation or postural changes may be 
employed. 
2. Active Management. (Reproductive Health Research, WHO, 2003)4, 
[FIGO, 2005] 
 - Administration of uterotonic agents within 1min of delivery of 
baby. 
- Controlled cord traction with counter traction. 
- Uterine massage after delivery of placenta. 
Active management was first described by Thilaganathan & 
collegues in 199838. 
Components of active management 
1.  Uterotonic agents. 
Within one min of delivery of baby palpate the abdomen to rule out 
additional baby and give any one of these 
a.    Oxytocin 10 1U IM 
b.    Ergometrine 0.2mg IM/IV 
c.  Syntometrine (1ampule) IM [0.5mg of ergometrine +5u oxytocin] 
d.    Misoprostol 40-600 mcg orally 
Prophylactic Methylergometrine is known to increase BP, hence 
avoided in PIH & cardiac disease. 
 2. Controlled cord traction: 
• Clamp the cord close to the perineum using sponge forceps. 
Hold the clamped cord and the end of forceps with one hand. 
• Place the other hand just above the woman’s pubic symphysis 
and stabilize the uterus by applying counter traction during 
Cord traction. This helps prevent inversion of uterus. 
• Keep slight tension on the cord and wait for a strong uterine 
contraction (2-3min) 
• When uterus becomes rounded or cord lengthens, very gently 
pull downward and backward on the cord to deliver the 
placenta. Do not wait for gush of blood before applying traction 
on the cord. Continue to apply counter traction to the uterus 
with other hand. 
• If placenta does not descend during 30-40seconds of Controlled 
Cord Traction (i.e. no signs of separation) do not continue to 
pull the cord. Wait for next contraction. 
• With next contraction, repeat Cord traction with counter 
traction. 
• As placenta delivers, the thin   membranes can tear off. Hold the 
placenta in two hands and gently turn it until the membranes are 
twisted. Slowly pull to complete the delivery. 
• If membranes tear, gently examine the upper vagina & cervix 
wearing high-level disinfected gloves & use a sponge forceps to 
remove any pieces of membrane that are present. Carefully 
examine the placenta for missing cotyledons or membranes 
If delivery of placenta is not achieved within 20-30mins, one 
should be ready for manual removal of placenta. 
If portion of maternal surface is missing or there are torn 
membranes with vessels suspect retained placenta. 
3.   Uterine massage 
- Immediately after delivery of the placenta, massage the fundus 
of uterus until the uterus is contracted. 
- Palpate for a contracted uterus every 15min & repeat uterine 
massage as needed during the first 2 hrs. 
- Ensure that uterus does not become relaxed (soft) after uterine 
massage is stopped.     
 When the oxytocic is not given until after the delivery of the 
placenta, it is necessary to relay on spontaneous uterine contraction for 
the complete separation from its attachment & then expel into vagina. 
Contractions are ineffective sometimes, hence there is a risk of 
hemorrhage with partial separation of placenta. 
 AIM OF THE STUDY 
To compare the efficacy of active management of third stage of 
labour with conventional method in reducing the blood loss during the 
third stage of labour in mothers at risk for PPH.  
MATERIALS AND METHODS 
Study design : Prospective case control study. 
Place of Study : Department of Obstetrics and Gynecology at the 
Institute of Social Obstetrics and Govt. Kasturba 
Gandhi hospital for women and children, 
Chennai. 
Study period : August 2006 to September 2007.  
Study population : All women delivered vaginally at Govt. Kasturba 
Gandhi Hospital during the study period were 
recruited for the study based on the inclusion and 
exclusion criteria. 
The study was approved by the hospital ethical committee. 
Inclusion criteria 
Following were the inclusion criteria on the basis of which the 
patients were included in the study. 
• Over distended uterus as in big baby, multiple pregnancy, 
hydramnios. 
• High parity (5 and above) 
• Abruptio placenta 
• Chorio amnionitis 
• Prolonged use of oxytocin 
• Previous H/O PPH 
• Anemia  
Exclusion criteria 
Patients with following risk factors were excluded from the study. 
• Heart disease 
• Epilepsy 
• Severe anemia 
• Traumatic PPH 
• Hepatic disorders 
Sample size :  total of 225 patients were selected and allotted into 2 
groups. 
Group I 
• Consists of patients who were given oxytocics within one 
minute of delivery of the baby followed by  
• Controlled cord traction with counter traction and  
• Uterine massage. 
Group II 
• Consists of patients who were allowed for Spontaneous delivery 
of placenta. 
• And were given 0.2 mg methylergometrine intravenously after 
delivery of placenta. 
Group I included 150 patients and Group II included 75 patients. 
The following factors were noted in all patients: 
i) Detailed history including age, parity, socioeconomic class, 
booking status and medical disorders if any  
ii) Physical examination – systemic examination and per abdomen 
examination. 
iii) Pulse rate and blood pressure at the time of admission into labor 
ward and after delivery of placenta. 
iv) Onset of labor 
v) Duration of I and II stage labor. 
vi) Nature of delivery. 
vii) Assessment of general condition of the patient immediately 
after delivery,  
viii) Uterine contour. 
ix) Duration of third stage labor: Time taken for the separation of 
placenta from the time of administration of oxytocics in group I 
and from the time of cord clamping in group 2 was taken as 
third stage duration. The lengthening of extravulval portion of 
cord was taken to indicate placental separation. 
x) Blood loss in the third stage of labor: Immediately after delivery 
of the baby when all liquor has drained out, the patient was 
brought to the edge of the table where an inflated Kelley’s pad 
was kept ready to place under the patient’s gluteal region. The 
lower end of pad was inserted into a measuring jar of 2 l 
capacity with 20 ml graduation. After 20 – 30 minutes, the clots 
in jar were weighed separately and added to the blood in jar. 
The average immeasurable blood loss due to episiotomy was 
taken as 50 ml (from the average calculated from normal 
vaginal delivery with episiotomy) same not included in blood 
loss calculated. Similarly when there was profuse bleeding from 
episiotomy, such patients were excluded. 
xi) The change in hemoglobin concentration following delivery by 
measuring the baseline hemoglobin soon after patient is 
admitted with labor pain to ward and repeating it 24 hours after 
delivery by Sahli’s hemoglobin estimation method. 
xii) Other intervention, if any 
xiii) Need for additional oxytocic therapy and blood transfusion if 
any were noted. 
xiv) Side effects of the methyl ergometrine like rise in blood 
pressure, nausea or vomiting if any was noted. 
xv) Other complications like retained placenta, and uterine 
inversion if any was noted. 
Statistical methodology : All the above parameters were assessed and 
the data analysed using paired t test and chi-
square test. A “p” value of < 0.05 was taken as 
statistically significant. 
OBSERVATION 
TABLE I:    AGE  DISTRIBUTION                        n=225 
AMTL Conventional 
Sl. No Age 
No of 
cases % 
No of 
cases % 
1 < 20 3 2 3 4 
2 21-25 51 34 24 32 
3 26-30 75 50 36 48 
4 31-35 12 8 6 8 
5 >35 9 6 6 8 
 
• Most of the patients in both study and control group were in the 
age group of 20-30 years (80-85%) 
• 2% cases in study group and 4% cases in control group were in 
the age group of less than 20 years. 
• 8% in control group and 6% in study group were above 35 
years. 
TABLE  II:       BOOKING STATUS                                  n= 225 
AMTL Conventional 
Sl. No Booking status No of 
cases % 
No of 
cases % 
1 Booked 147 98 75 100 
2 Un booked 3 2 - - 
• 98% of the patients were booked though they were selected at 
random. 
• All the patients in the control group were booked  
TABLE III: SOCIO ECONOMIC STATUS                      n= 225                                 
AMTL Conventional 
Sl. no Socioeconomic status 
No of cases % No of cases %
1 I -    
2 II -    
3 III -    
4 IV 18 12 12 16
5 V 132 88 63 84
 
• 88% of cases in study group and 84% of control group 
belonged to class V socio  economic status. 
 
 TABLE IV:   DISTRIBUTION OF PARITY           n = 225  
AMTL Conventional Sl. No Gravida 
No of cases % No of cases % 
1 Gravida 1  18 12 9 12 
2 Gravida 2  51 34 24 32 
3 Gravida 3 54 36 27 36 
4 Gravida 4 & 
Above 
27 18 15 20 
 
• 12% of study and control group were primi. 
• Most of the cases were multiparas. 
• 18% of study and 20% of control group were grand multipara. 
TABLE  V:    RISK FACTORS                      n = 225 
AMTL Conventional 
Sl.no Risk factors 
No of 
cases % 
No of 
cases % 
1 Over distended uterus 
a. big baby 
b. Hydramnios 
c. Multiple pregnancy 
63 
24 
15 
24 
42 
16 
10 
16 
30 
12 
6 
12 
40 
16 
6 
12 
2 Prolonged labour 18 12 9 12 
3 Anemia 42 28 21 28 
4 Grand multi 27 18 15 20 
 
• The major  risk factor in both study and control group was over-
distended uterus (40-42%) followed by anemia (28%), grand 
multipara (18-20%). Prolonged labor forms the remaining 
(12%) 
 
TABLE VI:   ONSET OF LABOUR                n = 225 
AMTL Conventional 
Sl. No Onset of labor 
No of cases % No of cases % 
1 Spontaneous 102 68 51 68 
2 ARM and oxytocin 21 14 12 16 
3 PGE2  alone 12 8 6 8 
4 PGE2 and oxytocin 15 10 6 8 
 
• Most of the cases (68%) had spontaneous onset of labour. 
• In the remaining (32%) labor was induced with ARM and 
oxytocin or with PGE2 gel alone or with PGE2 gel and oxytocin. 
 
TABLE VII:     NATURE OF DELIVERY                    n=225 
AMTL Conventional 
Sl.no Nature of delivery 
No of cases % No of cases % 
1 Labour Natural 78 52 42 56 
2 LN with Episiotomy 33 22 15 20 
3 Instrumental Vaginal Delivery 39 26 18 24 
 
• More than half the cases (52-56%) had normal vaginal delivery. 
• 24-26% of the cases had instrumental vaginal delivery either 
vacuum extraction or forceps.  
• In all these patients, traumatic PPH had been ruled out. 
 TABLE VIII   DURATION OF III STAGE OF LABOUR    n= 225 
AMTL Conventional 
Sl.no 
Duration of III 
stage (in 
minutes) No of 
cases % 
No of 
cases % 
1 < 2.5 57 38 -  
2 2.5-5 69 46 12 16 
3 5-7.5 18 12 18 24 
4 7.5-10 3 2 30 40 
5 > 10 3 2 15 20 
Chi square value = 18                       p value <0.001 
• In 84% of cases in study group, the duration of third stage of 
labor was less than 5 minutes where as 12% of control the 
duration of third stage labor was less than 5 minutes. 
• In about 60% of control group, the duration was more than 7.5 
minutes. Only 4% of study group the duration was more than 
7.5 minutes. 
TABLE – IX   DURATION OF III STAGE LABOR  
               STATISTICAL ANALYSIS                             n=225 
Sl.no Group No. of cases 
Mean 
duration in 
minutes 
S D ‘t’ Value 
‘p’ 
Value 
1 AMTL 150 3.72 2.65 8.6 <0.001 
2 Conventional 75 9.58 4.79   
 
• Mean duration of third stage labor in study was 3.27 min and in 
control was 9.58 min. 
• The difference in the mean duration of third stage of labor was 
6.31 min. 
• There is a statistically significant reduction in duration of third 
stage labor   (p<0.001)    
TABLE -X:   AMOUNT OF BLOOD LOSS       n= 225 
AMTL Conventional 
Sl.no Amount of blood loss in ml
No of cases % No of cases %
1 < 100ml 24 16 - - 
2 101-200 57 38 9 12
3 201-300 42 28 12 16
4 301-400 15 10 15 20
5 401-500 9 6 21 28
6 501-1000 3 2 15 20
7 > 1000 -  3 4 
 
Chi square value = 35                      p value <0.001 
• 16% of cases in study group had blood loss of less than 100ml. 
All the patients in study group had blood loss of more than 
100ml. 
• 2% of cases in study group had blood loss of >500ml. None 
>1000ml. 
• 24% of case in control group had blood loss of >500ml of 
which 3 (4%) had blood loss of >1000ml. 
 TABLE XI:  
BLOOD LOSS – STATISTICAL ANALYSIS        n= 225 
Sl.No Group No of cases 
Mean 
in ml S D 
‘t’ 
value 
‘p’ 
value 
1 AMTL 150 221.2 131.14 8.29 <0.001 
2 Conventional 75 395.5 217.56   
  
• The difference in the mean blood loss between the study and 
control group was 174.5 ml. 
• The mean blood loss in study and control group are 221.2 ml 
and 395.5 ml respectively. 
• There is a statistically significant reduction in the amount of 
blood loss. (p<0.001).  
TABLE XII:  RISK FACTORS AND BLOOD LOSS           n= 225 
Blood loss (ml) 
Sl.no Risk factor 
AMTL Conventional 
1 Overdistended uterus 219 382.01 
2 Prolonged labour 405.78 541.00 
3 Anemia 130.0 263.71 
4 Grand multi 185.91 311.89 
 
• Mean blood loss was maximum in patients with prolonged 
labor, followed by cases with over distended uterus and  grand 
multipara. 
• Most of the patients with prolonged labor had blood loss of over 
500 ml unless managed actively. 
TABLE XIII: HEMOGLOBIN DIFFERENCE (Hb%)         n=225 
AMTL Conventional 
Sl.no Hb difference in g/dl 
No of cases % No of cases %
1 < 0.75 63 42 6 8 
2 0.75 – 1.5 72 48 21 28
3 1.5 – 2.25 12 8 30 40
4 2.25-3 3 2 15 20
5 > 3 - - 3 4 
       Chi square value = 20                      p value <0.001 
• Most of the study group (90%)  had a hemoglobin difference of 
<1.5g/dl. 
• Most of the control group had a hemoglobin difference of  over 
1.5 g/dl  
• 3 patients in control group who had a blood loss of over 1000 
ml had a hemoglobin drop of  >3g/dl. 
TABLE XIV:  HEMOGLOBIN DIFFERENCE  
     STATISTICAL ANALYSIS                            n=225 
Sl. no Group 
Mean 
Hemoglobin 
fall 
S D ‘t’ value ‘p’ value 
1 AMTL 0.87 0.49 9.01 <0.001 
2 Conventional 1.7 0.72   
 
• Mean Hemoglobin difference in control group was 0.87 gm%. 
• Mean Hemoglobin difference in study group was 1.7 gm%. 
• Mean Hemoglobin difference between study and control group 
was 0.83 gm% which is of statistical significance. 
TABLE XV:  NEED FOR ADDITIONAL INTERVENTIONS 
AMTL Conventional 
Sl.No Intervention 
No of 
cases % 
No of 
cases %
Chi 
square 
value 
p value 
1 
Medical              
(additional 
oxytocics) 
8 6 21 28 107 <0.0001
2 
Surgical 
B lynch 
Internal iliac 
artery ligature 
Hysterectomy 
1 
1 
 
 
- 
0.6
 
 
 
 
6 
5 
1 
 
- 
8 
 
 
 
 
10.9 <0.0009
3 Blood transfusion 3 2 18 24 39 <0.0001
• 6% of cases in study group 28% of cases in control group 
required additional oxytocics either in the form of 10-20IU of 
oxytocin infusion or PGF 2α  250 mcg IM. 
• 6 patients whose uterus was still atonic even after adequate 
oxytocics underwent B-Lynch suturing to control the 
hemorrhage. 
• One patients in the control group underwent internal iliac artery 
ligation as they had bleeding even after B-Lynch. 
• All the patients with PPH needed blood transfusion in the 
immediate post partum period 
 
TABLE XVI: ANALYSIS OF COMPLICATION;                                 
POSTPARTUM  HEMORRHAGE. 
Sl. no Group Post Partum Hemorrhage % 
1 AMTL 3 2 
2 Conventional 18 24 
Chi square value = 39                p value<0.0001 
• The incidence of PPH (Blood loss >500 ml) in the study group 
was 2%. 
• In the control group it was 24 %. 
• 3 cases in the control group had severe PPH (Blood loss >1000 
ml). 
• None in study group had severe PPH. 
TABLE XVII: SIDE EFFECTS          n= 225  
AMTL  Conventional 
Complications 
No of cases % No of cases % 
Nausea 9 6 6 8 
Vomiting 6 4 3 4 
Rise in BP 21 14 12 16 
Inversion of 
uterus -  -  
Retained 
placenta -  -  
 
• Most common side effect noted in the patients studied was 
increase in blood pressure (10-20mm Hg either systolic or 
diastolic or both).  
• Less than 10% of the cases had nausea and vomiting. 
• None of the cases had retained placenta or uterine inversion in 
both the groups 
 
TABLE XVIII: FETAL WEIGHT                             n=261 
AMTL Conventional 
Sl. No Birth weight 
No of case % No of case % 
1 <2 Kg 26 14.9 14 16.1 
2 2-3 Kg 88 50.6 45 51.7 
3 3-4 Kg 44 25.3 20 23 
4 >4 Kg 16 9.2 8 9.2 
 
• 36 twin pregnancies resulted in the increase in the number of 
new born. 
• Most of the babies were appropriate for gestational age. 
• Multiple pregnancies and anemia complicating pregnancies 
resulted in more number of Low Birth Weight babies. Pre term 
labor is an important contributing factor to this. 
TABLE XIX: NEONATAL COMPLICATIONS               n=261 
AMTL Conventional 
Sl. No Fetal outcome 
No of case % No of case % 
1 Pre term 36 20.7 18 20.7 
2 Respiratory distress 22 12.6 11 12.6 
3 Low birth weight 41 23.6 20 23 
4 Large for dates 16 9.2 8 9.2 
5 NICU admission 44 25.3 21 24.1 
Chi square value = 2           p value = 0.9 
• Some of the babies had more than one complications like low 
birth weight and preterm. 
• Some of the preterm babies also had respiratory distress. 
• LGA babies were admitted for observation. 
• There is no significant difference in Neonatal morbidity in 
both the groups.    
DISCUSSION 
This randomized control trial comparing the efficacy of active 
management of third stage labor with conventional methods in the 
prevention of PPH was undertaken in 225 patients who had any of the 
risk factors of PPH.  
The results are as follows: 
Table 1: Most of the patients in this study were in age group 20 – 30 yrs 
(80 – 84%) Advancing maternal age is related to increased risk 
of death due to hemorrhage (Callaway et al, 2005).40 Incidence 
of PPH is higher in women under the age of 20 years (Ian 
Donald).41 
Table 2:  98% of study group and all in control group were booked. Due 
to the increased awareness through media and dedicated health 
personal and increased availability of facilities within their 
reach made every women have a regular AN check up. 
Table 3:  Since ours is level III referral unit catering to below poverty line 
population, all the patients were in socioeconomic class of 
either IV (12 – 16%) or V (84 – 88%) 
Table 4: 12% were primigravida and 34 – 32 % were second gravida 
36% were third gravida and 18-20% were multi gravida. 
Multiparity is the most common cause of PPH (Ian Donald).41 
Nulliparity is a risk of PPH with an odds ratio of 1.5 (Combs et 
al).42 Fuchs and collegues (1985):43 incidence of PPH in para 4 
or more (2.7%), increased 4 fold compared with general 
population. Babinski (1999):44 In low parity the incidence was 
0.3% and in para 4 or more it was 1.9%. Feeney et al45: 
incidence of PPH in grand multipara is 13% In our study, one 
grand multipara in the control group had PPH  
Table 5: 44% of study group had over distended uterus (Big Baby – 
16%, Hydramnios 10%, multi pregnancy 16%). 12% had 
prolonged II stage, 28% had anemia. According to various 
literature: PPH occurred in 2-11% of all deliveries (Newton 
1961)47. 20% of women have no risk factor for PPH (Varner, 
Metal)49 PPH was reported to occur is 6 – 22% of twin 
deliveries (Newton 1986). Recurrence of PPH is 25% (Dew 
Hurst, CJ et al).33 Incidence of PPH in twin pregnancy is high 
with an odds ratio of 3.3 (Combs 1991)42. Conde Agudelo53 and 
co-workers (2000) showed that PPH was increased 2 fold in 
twin pregnancy. 
Table 6: 68% of study group & 70% of controls had spontaneous onset 
of labor. In the remaining cases labor was induced with either 
ARM & Oxytocin, PG E2 gel or PG E2 gel with Oxytocin. 
Induced labor is 2.2 times more prone for PPH. Augmented 
labor is a high risk for PPH with an odds ratio of 1.7 (Combs 
1991)42. Oxytocin more common cause of PPH than 
prostaglandin gel. PPH is more common in induced or 
augmented labor (Kaster et al).48 
Table 7: 74% of study group had normal vaginal delivery. 26% of cases 
had instrumental vaginal delivery. (12% vacuum, 14% 
Forceps). Incidence of atonic PPH was 7.3% in vacuum and 
12.5% in forceps deliveries (Williams et al 1981)51. Forceps and 
Vacuum has increased risk of PPH with an odds ratio of 1.7 
(Combs 1991).42 In this study the incidence of atonic PPH was 
7.6% with instrumental vaginal delivery. 
Table 8: In 84% of study group & 28% of control, the duration of third 
stage was less than 5 min. In most of the patients in the control 
group (72%) the duration of third stage labor was > 5 min.  2% 
of the study group who were induced with PGE2 gel, had third 
stage duration of 15-20 minutes. 20% of the control group had 
III stage duration more than 10 min and they were either 
multipara or had induced labor. 4 patients in the control group 
had  III stage duration more than 20 min and they had both 
prostaglandin gel and oxytocin drip during the first stage of 
labor. Duration of third stage labor is longer with induced labor, 
multiparity, preterm delivery and small placenta. ( Adelusi et al 
1997).52 Laros 199153 studied 12,275 singleton vaginal 
deliveries. Median III stage duration is 6 min and for 3.3% of 
these women it was more than 30 min.  
Table 9:   The mean duration of III stage labor in study group was 3.72 
min and in control was 9.58 min. This difference in the duration 
of III stage labor is statistically significant. (p<0.001) 
• Cochrane review 200229B showed that the III stage duration 
is significantly shortened (80%) in Active group as 
compared to the physiological group with a relative risk of 
0.18 and 95% confidence interval of 0.14-0.24. 
• In the Bristol trial7 the mean III stage duration was 5min in 
Active and in physiological group it was 15 min which was 
statistically significant with a p value of <0.001. 
• In  Hinchingbrooke  trial6 the mean III stage duration  was 
8 min in Active group and 15 min in physiological group 
with a p value of <0.001. 
• Thilaganathan et al38 showed that the duration of third 
stage was significantly longer in physiological group with 
a p value of <0.001. 
• Tsu et al36 had a 80% reduction in the III stage duration 
with Active Management of Third stage Labor with an 
odds ratio of 10.20, 95% confidence interval 0.11-0.35. 
• Prendiville et al29A showed that the mean difference was -
9.77 min with a confidence interval of -10 to -9.53. 
Table 10:  54% of study group and only 12% of control had blood loss of 
less than 200ml. About 64% of the control group had blood loss 
of > 400ml as compared to 8% in study group. 
• In our study average blood loss in normal labor was 143 ml 
and 290 ml in study and control group respectively and 
average blood loss in instrumental delivery was 237 ml and 
405 ml in study and control group respectively. 
• Wallace (1967)55 showed that average blood loss with 
forceps was 400 ml and following normal vaginal delivery 
was <300 ml. 
• 4% of the women had blood loss of >1000 ml. All of them 
were treated with prostaglandin gel and oxytocin. 
• Pritchard and associates (1962)52 found that 5% of women 
delivering vaginally lost >1000 ml of blood. 
• Life threatening hemorrhage occurs in 1 per 1000 
deliveries (Lewis and Drife 1998)53 
Table 11: The mean blood loss in study group was 221 ml and in the 
control group, it was 395 ml. Thus the reduction in blood loss 
with active management of third stage labor is statistically 
significant (p<0.001) 
• Pendiville et al29A showed that difference in mean blood loss 
was -79.33 ml with a 95% confidence interval of -94.39 to -
64.37. 
• Thilaganathan et al38 showed no significant reduction in the 
blood loss (p>0.5). 
• Joshua et al34 had a statistically significant  mean difference 
of -75 ml (p<0.02). the blood loss in the active group was 
355 ml and in physiological group, 430 ml.   
• In our present study the mean difference was -174 ml. A 
further reduction of blood loss in the active management 
group resulted in the increased mean difference compared to 
other studies. 
Table 12:  Blood loss was maximum in patients with prolonged labor 
followed by over distended uterus, grand multipara and finally 
the anemia group. Uterine exhaustion following prolonged 
labor is the principle cause of PPH (Ian Donald)41. Risk of 
PPH in prolonged labor is 12.5% (Freidman)57. Prolonged 
labor has an increased risk of PPH with an odds ratio of 2.9 
(Combs 1991)42. Multiple pregnancy has 4.5 times increased 
risk of PPH (Stones et al).58 Birth weight of  >4 kg is 1.9 times 
more prone for PPH (Stones et al).58 The average blood loss 
was more in induced group (226 ml and 325 ml) than the 
spontaneous group (162 ml and 239 ml) in this study. Blood 
loss was more with induction (Combs et al, Kastner et al, 
Stones et al)42,50,58. As most of the cases with prolonged labor 
followed by those with overdistended uterus were induced 
with prostaglandin gel or oxytocin, this factor also contributed 
to more blood loss in this study.   
Table 13: In this study the incidence of PPH was 2 % in study group and 
24% in control group. 
• In Hinchingbrooke trial6 the incidence of PPH in active 
management group was 6.8% and in physiological group 
was 16.5% with an odds ratio of 2.42 and 95% confidence 
interval of 1.78-3.3. (p<0.0001) 
• In the Bristol trial7 the incidence of PPH was 5.9% with 
active management and 17.9% with physiological 
management whose odds ratio was 3.13 and 95% confidence 
interval of 2.3 -4.2.  
• Predenville et al29A showed that incidence of PPH can be 
reduced by 30 – 40% with Active Management of Third 
stage of Labor. 
• The meta-analysis of 5 trials in Cochrane review 200229B 
showed a 60% reduction in incidence of PPH of >500 ml 
and PPH >1000 ml. Relative risk of 0.38 and 0.33 
respectively and a 95% confidence interval of 0.32-0.46 and 
0.21-0.51 respectively. For every twelve patient receiving 
active management rather than physiological management, 
one PPH was prevented.   
• Tsu et al36 showed a 34% reduction in incidence of PPH with 
an odds ratio of 0.66 and 95% confidence interval of 0.45-
0.98.  
• Poeschmann28 et al showed a 35% reduction in incidence of 
PPH. 
• The incidence of PPH in active and physiological group 
were 5% and 14% (Chelmov et al)31. In the trial by Joshua et 
al34 it was 10% and 26% respectively.               
• The incidence of severe PPH in this study was 0% and 4% 
respectively in the two groups. In the study by Chelmov et 
al31 it was 0.9% and 3% respectively and in the one by 
Joshua et al34 it was 1% and 6% respectively. 
• The severe PPH in the 3 cases in this study was due to 
prolonged labor who also had induction. One delivered by 
labor natural, other two had instrumental vaginal delivery.  
Table 14,15:  Hemoglobin  difference of < 1.5 gm was noted in 90% of 
cases in study group and 48% of cases in control group.  
• In nearly 52% of the patients in control group the fall in 
hemoglobin was > 1.5 gm. 
• Thus active management of third stage labor significantly 
reduces the maternal morbidity due to anemia.  
• The maximum fall in hemoglobin in the study group was 
2.75g/dl with a blood loss of 900 ml. 
• The maximum fall in hemoglobin in the control group was 
3.75g/dl with a blood loss of 1300 ml. 
• Mean Hemoglobin difference was 0.87 gm and 1.7 gm in 
study and control group respectively which is of statistical 
significance. 
• Cochrane systemic review 200229B- identified a reduced risk 
of anemia in Active Management of Third stage of Labor as 
compared to Expectant Management (number needed to treat 
– 27). 
• Chelmov et al31 had 3% fall in Hemoglobin in Active 
Management of Third stage of Labor compared to 6% in 
physiological group. 
• Joshua et al34 had a mean hemoglobin decline of 1.7 vs 2.2 
g/ dl (p<0.001). Hemoglobin decline was 5% and 27% 
respectively. 
• Prendiville et al29A had a significant (60%) reduction in 
hemoglobin in the physiological group with a relative risk of 
0.4 and 95% confidence interval of 0.29-0.55. 
Table 16: 6% of cases in study and 24% of cases in control group needed 
additional oxytocics in the form of either 10-20IU of oxytocin 
infusion or PGF2ALPHA 250 mg IM, which is of statistical 
significance (p<0.0001). 
 
 
 
Therapeutic oxytotics       AMTL                      Conventional 
Bristol trial 7                        6.4%                           29.7% 
Hinchingbrooke6                 3.2%                            21.1% 
Chelmov et al31                   4%                               17% 
Thilaganathan et al38           0.9%                              7% 
Present study                       6%                               24% 
• Tsu et al36 had a significant need of additional oxytocic in 
the physiological group with an odds ratio of 0.68 and 95% 
confidence interval of 0.49-0.94. 
• Cochrane meta-analysis29B showed a 80% reduction in the 
need for additional oxytocic with a relative risk of 0.2 and a 
95% confidence interval of 0.17-0.25. (Number Needed to 
Treat = 7). 
Surgical intervention: the need for surgical intervention is reduced 
significantly (p<0.0009). 
• 6 patients with atonic uterus even after adequate oxytocics 
underwent B-Lynch suturing to control the hemorrhage.  
• One patient in the control group underwent internal iliac 
artery ligation. In this patient atonicity persisted in spite of 
all medical management and in view of excessive bleeding 
internal iliac artery ligation was done.  
• Surgical intervention due to uterine atony was more 
prevalent following prolonged labor (Kaster 1991)50. 
Blood transfusion:  The need for blood transfusion was 2% and 24% in 
the active and conventional group respectively which is statistically 
significant (p<0.0001). 
• In Hinchingbrooke6 trial rate of blood transfusion was 0.5% 
and 2.6% in both the groups respectively with an odds ratio 
of 4.9 and 95% confidence interval of 1.68-14.25. 
• In the Bristol7 trial the rate of blood transfusion was 2.1% 
and 5.6% respectively with an odds ratio of 2.56 and 95% 
confidence interval of 1.57-4.19. 
• Chelmov et al31 needed 0.8% and 2% of transfusion in the 
two groups respectively. 
• In the trial by Joshua et al34 none of the active group needed 
blood transfusion. Blood transfusion in the other group was 
3%  (p<0.01) 
• The higher percentage of blood transfusion in our study was 
due to the fact that most of our clients have a low 
prepregnant hemoglobin level and they enter pregnancy as 
anemic or borderline anemic. So they do not tolerate even 
the small amount of blood loss which is tolerated by an 
average western woman.              
Table 17: In our study 6-8% of the cases had nausea and 4% had 
vomiting. 14-16% of the patients had rise in BP (10-20 mm of 
Hg)  which soon returned to normal. 
• Prendiville et al29A had an increased rate of nausea and 
vomiting in the active management group due to 
ergometrine. The rise in BP in this group was also due to 
ergometrine. 
• Chelmov et al31 also had an increased rate of nausea and 
vomiting due to ergometrine. 
• Saraschandrika et al59 reported no significant alteration in 
blood pressure in mild PIH patients when prophylactic 
methyl ergometrine was used. 
Table18,19: The rate of admission to NICU is almost similar in both the 
groups in our study(p=0.9). No significant change in 
morbidity and mortality of the neonate (Prendiville et al29A, 
Rogers et al6) The risk of pre term labor is increased in 
anemia complicating pregnancy (Klebanoff 1991, Liberman 
1987)53. Scanlon 2000 showed there is a 1.3 -1.8 fold risk of 
Small for Gestational Age with anemia. Powers and Kiely 
(1994)53 showed that twins accounted for 14% of LBW 
neonates. Kleinman (1991)54 showed that the risk of 
asphyxia was 4-5 times that in singleton. Houlton (1981)54 
had a 50% risk of pre term and 25% risk of intrauterine 
growth restriction among twins. 
 SUMMARY 
This present prospective case control study “Comparative study of 
efficacy of Active management of third stage labor versus conventional 
method of giving methylergometrine after delivery of the placenta in the 
prevention of PPH in at risk PPH mothers” was carried out at Institute of 
Social Obstetrics, Kasturba Gandhi Hospital, Madras Medical College, 
Chennai, during the period August 2006-July 2007. Total of 225 cases 
who had any of the risk factors for PPH were included in the study and 
were grouped into two categories.  
The efficiency of active management of III stage labor   and 
conventional method in reducing postpartum blood loss was compared. 
Results were statistically analysed. 
¾ There was a statistically significant decrease in the duration of 
III stage in study group with a p value <0.001. 
¾ The blood loss was significantly reduced with a p  <0.001. 
¾ The fall in hemoglobin was also significantly reduced with a p 
value of <0.001. 
¾ Active management significantly reduced the incidence of PPH 
(p<0.0001) and the need for oxytocics (p<0.0001) and the rate 
of blood transfusion (p<0.0001). 
¾ Side effects of using oxytocics was very minimal.  
¾ Neonatal morbidity was similar in both the groups. 
¾ Thus active management improves the quality of life by 
reducing the morbidity and mortality due to PPH. 
CONCLUSION 
 Active management of third stage of labor should be the routine 
management of choice for every women expecting to deliver a 
baby by vaginal route in a maternity hospital. 
 IV oxytocics given immediately after delivery of baby is more 
effective than when given after delivery of placenta in 
preventing the postpartum hemorrhage. This can easily be timed 
even by paramedical personnel. 
 Controlled cord traction with counter traction is effective in 
preventing uterine inversion and entrapment of the placenta. 
 The need for additional intervention is reduced by giving 
oxytocic before delivery of placenta.s 
 The side effects of methyl ergometrine, rise in blood pressure 
and nausea and vomiting is not so severe as compared to its 
benefits and can be well tolerated and controlled. 
 Methyl ergometrine is to be avoided in patients with PIH and 
cardiac patients. 
So, in countries with high maternal mortality rate especially due to 
PPH and higher morbidity, evidence based practices that prevent PPH 
and its associated mortality and morbidity is an important way to improve 
women’s health. 
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PROFORMA 
COMPARATIVE STUDY OF ACTIVE MANAGEMENT OF THIRD 
STAGE LABOR WITH CONVENTIONAL METHOD IN THE 
PREVENTION OF PPH IN AT RISK  MOTHERS   
NAME:                    AGE:           UNIT:            IP No. 
 
SOCIO ECONOMIC STATUS:           DATE, TIME:        
MARRIED: 
BOOKED/ UNBOOKED 
OBSTETRIC FORMULA:  G   P   L   A 
LMP                   EDD 
COMPLAINTS: 
PAST HISTORY:   
GENERAL EXAMINATION: anemia +/-                   Pedal edema +/- 
Vitals: PR:       BP:         RR:              Temp: 
Breast                             Thyroid                Spine           
Height                    Weight     
SYSTEMIC EXAMINATION:   CVS               RS 
P/A 
INVESTIGATION:  Hemoglobin 
                                 Urine albumin                  sugar 
                                  Blood Group and Type  
 
RISK FACTORS: Big baby 
                               Hydramnios 
                               Multiple pregnancy 
                               Anemia 
                               Prolonged labor 
                               Grand multipara 
 
ONSET OF LABOR:  Spontaneous 
                                     Induced-ARM and oxytocin 
                                                   PGE2 gel 
                                                   PGE2 gel with oxytocin 
 
DURATION OF LABOR:   I stage 
                                             II stage 
 
NATURE OF DELIVERY: LN/ LN with Epi/ IVD 
 
MANAGEMENT OF III STAGE:  ACTIVE 
                                                         CONSERVATIVE 
 
DURATION OF III STAGE: 
AMOUNT OF BLOOD LOSS: 
 
COMPLICATION:    PPH 
                                   Retained placenta 
                                   Others 
 
Any other drug given: inj. oxytocin    
                                    Inj. prostaglandin 
 
SURGICAL INTERVENTION: B-lynch 
                                               Internal iliac artery ligation 
                                               Hysterectomy 
 
BLOOD TRANSFUSION: No. of units 
 
FALL IN HEMOGLOBIN 
 
OUTCOME       FETAL 
                          MATERNAL                                                
 
 
SL.
NO NAME I.P. NO AGE
S.E. 
CLASS BOOKS PARITY
RISK 
FACTOR
ONSET OF 
LABOUR
NATURE OF 
DELIVERY DURATION BLOOD LOSS
MEDICAL 
INTERVE
NTION
 SURGICAL 
INTERVENTION  BL.TRANS PPH
FALL IN 
HB
SIDE 
EFFECTS
BIRTH 
WT
FETAL 
COMP
1 Poornima 5233 27 4 1 3 3 1 1 1 125 0.9 1.95 1,3,5
2 Noorunisha 8403 26 5 1 4 4 1 1 4.5 150 0.9 2.8
3 Alima 7725 23 5 1 3 3 1 1 1 75 0.75 1.85 1,3,5
4 Sasirekha 6744 27 5 1 3 1A 3 2 4.5 150 1.2 1 3.8
5 Kavitha 1021 33 5 2 4 4 1 1 4 150 0.8 2.7
6 Karpagam 8347 24 5 1 1 1B 2 2 4.75 150 0.9 2.8
7 Kowsalya 3855 22 5 1 2 1A 3 3 4 150 0.5 4.1 4
8 Anitha kumari 3214 27 5 1 1 3 1 3 1.25 50 0.5 1.9 1,2,3,5
9 Subha 4278 28 5 1 3 1A 3 3 3 125 0.8 4.2 4,5
10 Ayesha 4078 36 5 1 2 2 4 2 15 350 1 0.9 3.2 2,5
11 Jainam bee 5477 27 5 1 4 4 1 1 4.5 175 0.9 2.6
12 Parameswari 1864 24 4 1 3 3 1 1 1 150 0.4 3 1.9 1,3,5
13 Deepa 9011 29 5 1 3 2 4 3 7.25 900 B-Lynch 1 1 2.5 3.2
14 Suraiah 6488 26 5 1 3 1B 2 1 4.5 225 1.1 2.7
15 Prinitha devi 3324 37 5 1 4 4 1 1 6.75 325 1.7 2.5
16 Parvathy 4611 34 5 1 4 4 1 1 1.25 50 0.3 2.5
17 Kokila 3153 28 5 1 3 1A 2 2 2.75 125 0.3 4.1 4,5
18 Renuga 5157 24 4 1 2 1C 1 2 3.25 225 0.9 1.9,2.2 1,3,5
19 Santhana laks 4598 27 5 1 2 1C 1 1 4 250 1 3 2.3, 2.4
20 Poongavanam 8865 22 5 1 2 2 4 3 6.5 425 1 1.25 3.1 2,5
21 Amsa veni 8917 26 4 1 2 1A 3 3 4 250 1.25 4.2 4,5
22 Vidhya 1309 27 5 1 3 1C 1 1 3 225 1.4 1.8, 2.1 1,2,3,5
23 Hajeera 3571 27 5 1 2 1A 1 3 3.25 225 0.9 4.1 4,5
24 Elavarasi 1543 23 5 1 2 2 2 3 7 325 1 1 2 3.4 2
25 Chitra 7738 19 4 1 1 1C 1 1 1 125 0.9 2.2, 2.5
26 Indirani 8156 38 5 1 3 2 4 3 7.5 325 1 1.6 3 3.1
27 Malathi 7628 27 5 1 3 1C 1 1 1.25 124 0.3 1.9, 2.1 1,3,5
28 Arokya mary 3977 28 5 1 3 1A 1 2 3.5 225 1 3.9
29 Rashitha 6844 29 5 1 3 2 4 3 9 425 1 1.75 3 2
30 Poongodi 6754 31 5 1 3 3 1 1 1.25 150 0.2 1.8 1,2,3,5
31 Vijayalakshmi 2409 22 5 1 3 1B 2 1 1.25 150 0.1 2 2.6
32 Jeenath 4956 28 5 1 4 4 1 1 1 50 0.2 2.6
33 Salima 8563 21 4 1 3 2 4 3 7.5 325 1 1.75 3.1 2
34 Vidhya 6299 26 5 1 2 1C 1 2 1.25 75 0.3 2.25, 2.5
35 Ramani 1011 22 5 1 3 3 1 1 2 175 0.2 2 1.75 1,3,5
36 Sudha 8426 26 5 1 2 2 4 2 7.25 375 1 1.2 3.2 2
37 Sumathy 3087 29 5 1 1 3 1 3 2 175 1.2 3 1.7 1,2,3,5
38 Sarasvathy 7534 21 5 1 1 1B 2 2 4 175 0.3 3 2.6
39 Jeyanthi 6633 26 5 1 2 1B 2 2 2.75 225 1.1 2.9
40 Sarala 1678 29 5 1 4 4 1 1 3 175 0.2 2.9
41 Arul Elizabeth 3623 30 5 1 1 2 4 3 7.25 375 1 0.8 3.4
42 Jamuna 3523 28 5 1 3 2 4 3 6.5 425 1 1.7 3.6 2,5
43 Vasanthy 2376 32 5 1 2 1C 1 2 1.5 175 0.4 1 1.8, 2.1 1,3,5
44 Asraff 3908 23 4 1 1 1B 2 2 5 225 0.9 2.8
45 Kasthuri 3066 24 5 1 2 3 1 3 5 175 0.2 1.8 1,3,5
46 Nirmala 4877 26 5 1 3 3 1 1 2 75 0.2 3 1.9 1,3,5
47 Yamuna 6188 24 5 1 4 4 1 1 2.75 275 1 1 2.8
48 Ramya 1670 22 5 1 2 1C 1 2 2 175 0.2 2.4, 2.6
49 Bharathi 4167 21 5 1 1 1C 1 1 2.25 50 0.4 2.4,2.5
50 Bindhu 1457 38 5 1 4 4 1 1 2.25 150 0.2 2.7
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NO NAME I.P. NO AGE
S.E. 
CLASS BOOKS PARITY
RISK 
FACTOR
ONSET OF 
LABOUR
NATURE OF 
DELIVERY DURATION BLOOD LOSS
MEDICAL 
INTERVE
NTION
 SURGICAL 
INTERVENTION  BL.TRANS PPH
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HB
SIDE 
EFFECTS
BIRTH 
WT
FETAL 
COMP
51 Bharisha 3866 27 5 1 1 3 1 3 2.25 90 0.4 3 1.7 1,2,3,5
52 Salomi 2765 26 5 1 2 1B 2 2 4 275 1 2.7
53 Muthulakshmi 4732 23 5 2 3 3 1 1 1.75 90 0.4 1.8 1,3,5
54 Maragatham 8339 19 5 1 3 3 1 1 2 150 0.9 1 2.35
55 Shyamala 5575 37 5 1 4 4 1 1 3.5 225 0.2 3 2.6
56 Desa pattu 4777 27 5 1 3 3 1 1 2 90 0.6 2.25
57 Gomathi 2235 24 5 1 3 3 1 1 1.75 80 0.8 2.4
58 Syed Ali Fathim 4467 32 5 1 4 4 1 1 2.75 250 0.4 3 2.75
59 Benazir begum 3644 26 5 1 2 3 1 3 1.75 150 0.8 1.9 1,3,5
60 Suganthi 8793 21 5 1 1 1B 2 1 2.75 375 1 0.9 2.6
61 Sasi kala 1654 28 5 1 3 1A 2 2 7.5 375 1 0.9 1 4.1 4
62 Junnu 7955 25 5 1 2 3 1 3 2.25 150 1 2.6
63 Vanitha 3426 26 5 1 1 1C 1 1 5 250 0.9 2.5,2.5
64 Jasmine 5634 24 4 1 4 4 1 1 1.75 250 0.9 2.9
65 Saranya 7043 36 5 1 2 1A 3 3 3 275 0.8 3 3.8
66 Nagaveni 7085 33 5 1 4 4 1 1 4.5 275 1 2.8
67 Amala 3806 28 5 1 3 1A 2 2 3.5 275 1.2 4.2 4,5
68 Vaidehi 2488 27 5 1 2 3 1 3 1.75 275 0.9 2.6
69 Nagaveni 5867 21 5 1 1 1C 1 1 3 275 0.6 1,2 1.75, 2.1 1,2,3,5
70 Jeyamala 6623 29 5 1 3 3 1 1 2.25 125 1 2.5
71 Sarathi 8257 30 5 1 3 2 2 3 6 425 1 1.3 3.5 2
72 Devimani 7357 26 5 1 2 1A 1 3 2.75 275 0.5 4.2 4,5
73 Farsana 8639 27 5 1 2 3 1 3 2.25 125 0.4 2.4
74 Karpagam 4822 26 4 1 3 3 1 1 3.5 75 1.2 3 2.45
75 Mathi 8657 23 5 1 2 1C 1 2 1.75 275 0.9 2.5,2.5
76 Selvi 2086 28 5 1 4 4 1 1 1.75 75 0.7 2.7
77 Veena 2679 21 4 1 2 1B 2 2 4 125 1.1 2.5
78 Kairunisha 9300 29 5 1 3 2 4 3 9 750 1 1 1 2.5 3.6 2
79 Nushrath nisha 5623 30 5 1 3 1A 1 2 3.5 275 0.9 3 4.1 4,5
80 Saha padma 1345 23 5 1 3 3 1 1 4 150 0.9 2.5
81 Gunavathy 6124 24 5 1 2 1A 1 2 4.5 375 1 0.9 3 3.9
82 Mobina begum 6265 31 5 1 2 3 1 3 1.5 125 0.4 2.6
83 Chandra 8827 28 5 1 3 1B 2 1 1.75 80 0.6 3.2
84 Gowri 8235 29 5 1 1 1C 1 1 4.5 125 0.7 2.4,2.6
85 Uma rani 5155 26 5 1 4 4 1 1 3.25 125 0.4 3 2.6
86 Nathiya 6511 28 5 1 1 1A 1 3 5.5 450 1 1.9 4.2 4
87 latha 7276 24 5 1 2 1C 1 2 3.5 250 0.9 1.9, 2.25 1,3,5
88 Parameswari 2389 29 5 1 2 3 1 3 1.25 150 0.7 3 2.6
89 Gajalakshmi 7844 27 4 1 2 1C 1 2 4 150 1.3 2.45,2.5
90 Sarapadma 4000 24 5 1 3 3 1 1 2.75 90 0.5 2.5
91 5743 32 5 1 4 4 1 1 3.5 250 1.2 2.5
92 Valli 7293 22 5 1 2 3 1 3 1.75 150 0.5 2.4
93 Mageswari 7845 26 5 1 4 4 1 1 3 150 0.7 3.2
94 Hemlatha 8793 23 4 1 2 3 1 3 1.25 175 0.7 2.6
95 Jalamma 8044 24 5 1 2 2 4 2 20 450 1 2 3 3.5 2,5
96 Sirisha 1113 23 5 1 3 4 1 1 3 90 0.5 3.1
97 Devimani 7156 27 5 1 3 1C 1 1 2.75 175 0.5 2.5,2.5
98 Charumathi 2493 24 5 1 2 3 1 3 2 175 0.7 2.5
99 Meena 6054 28 5 1 4 4 1 1 3.25 250 1 3.4
100 Lalitha 1567 25 4 1 3 3 1 1 1.75 175 0.5 3 2.5
101 amul 7188 32 5 1 3 1A 1 2 3.5 175 1.1 3 3.75
102 Praveena 7394 30 5 1 1 1B 2 1 3.5 250 1 3.25
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NO NAME I.P. NO AGE
S.E. 
CLASS BOOKS PARITY
RISK 
FACTOR
ONSET OF 
LABOUR
NATURE OF 
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NTION
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INTERVENTION  BL.TRANS PPH
FALL IN 
HB
SIDE 
EFFECTS
BIRTH 
WT
FETAL 
COMP
103 Jothy 8593 27 5 1 3 2 4 3 6.5 450 1 2 3.4
104 Vijayalakshmi 2345 28 5 1 2 3 1 3 1.75 100 0.5 2.5 3
105 Angalammal 3754 29 5 1 3 2 4 2 3 175 1.1 3.5 2,5
106 Nagammal 1789 33 5 1 4 4 1 1 1.75 175 0.5 3.1
107 suriya 2567 29 5 1 1 1B 2 1 2.75 250 1 3.2
108 Raja mary 1340 28 5 1 3 1C 1 1 3 250 1.2 1.8, 2.2 1,3,5
109 Tamilarasi 6853 24 4 1 4 4 1 1 3.5 175 0.4 3.1
110 Gayathri 7497 23 5 1 2 1B 2 1 4.5 175 0.9 3.5
111 Kavitha 5087 30 5 1 4 4 1 1 3.75 275 1.5 3.2
112 Rahini 6077 26 5 1 3 3 1 1 1.75 100 0.4 2.4 3
113 Shoba 4698 24 5 1 3 3 1 1 2 175 0.6 2.5 3
114 ShaliniChitra 1345 29 5 1 3 1A 1 2 6.75 375 1 1.4 4.1 4,5
115 Anitha kumari 8138 23 5 1 3 3 1 1 4 175 1.1 2.5
116 Lakshmi 1780 34 5 2 4 4 1 1 2 175 0.5 3.3
117 Senthamarai 6344 24 5 1 1 1A 1 3 4.5 275 1 3.8
118 Veerama 8065 28 5 1 3 3 1 1 2 100 0.4 2.7
119 Gunavathy 1234 23 5 1 3 3 1 1 1.75 150 0.5 3 2.6 3
120 rukmani 1963 26 5 1 3 3 1 1 2 100 0.2 2.5
121 Brinda 8967 24 4 1 1 1C 1 1 2 150 0.2 1.9, 1.8 1,2,3,5
122 Latha 1112 30 5 1 3 2 2 3 7.5 450 1 1.7 1 3.6 2
123 Mary 1097 26 5 1 3 3 1 1 1.75 100 0.3 2.4 3
124 Kavitha 1456 37 5 1 3 3 1 1 1.75 150 1 2.5
125 Yogalakshmi 7429 27 5 1 2 1A 3 2 4 275 0.9 4.2 4
126 Panjalai 3777 24 5 1 2 1A 3 2 7 350 1.2 3.9
127 Rajeswari 2392 24 4 1 2 3 1 3 2.25 150 0.6 2.8
128 Revathi 6598 28 5 1 4 4 1 1 2.25 100 0.4 3.2
129 Radha 2401 22 5 1 2 3 1 3 2.25 175 0.2 2.6
130 vanimaheswar 1119 27 5 1 4 4 1 1 3.5 175 0.8 1,2 3.25
131 sasikala 5235 23 4 1 2 1C 1 2 4.5 275 0.7 2.4,2.5
132 Dhanalakshmi 4378 29 5 1 3 1C 1 1 4 275 2 1.7, 1.9 1,2,3,5
133 manimala 2986 19 5 1 2 1A 3 3 6.5 350 1.3 4.2 4,5
134 Vimala 5976 36 5 1 2 1C 1 1 4.5 275 0.5 2.5,2.6
135 Malini 5322 26 5 1 3 3 1 1 2.25 100 0.4 2.7
136 Parameswari 7956 26 5 1 2 1C 1 1 1.75 175 0.5 1.7, 2.1 1,2,3,5
137 Venda 1788 36 5 1 4 4 1 1 1.75 175 0.7 3 3.15
138 Unnamali 3854 26 5 1 2 1A 3 3 4.5 275 1.4 4.1 4
139 Kanchana 6356 26 5 1 2 1B 2 1 5 250 1.4 3.2
140 Manonmani 2555 23 5 1 2 1B 2 1 4.75 225 1.2 3.2
141 Glori 1766 27 5 1 4 4 1 1 3.6 225 1.3 1,2 3.1
142 Ganga 1230 23 4 1 2 1C 1 1 3.75 225 1.4 1.9, 2.2 1,3,5
143 Nandhini 7634 35 5 1 4 4 1 1 2 90 0.5 3.2
144 Bhuvaneswari 2875 24 5 1 2 1A 3 2 7 350 1.5 3.8
145 Nithya 6985 27 5 1 2 1C 1 1 3.5 225 1 1.75, 2.1 1,3,5
146 Sneha 1116 28 5 1 3 3 1 1 2 175 0.5 2.9
147 Manjula 1763 23 5 1 2 1A 3 2 4.5 350 1.1 4.2 4,5
148 Lakshmi 6977 24 5 1 2 2 4 3 9 800 1 1 1 2.5 3.5 2,5
149 Eswari 6432 29 5 1 3 1A 3 2 4.75 225 1 4.2 4,5
150 Sumathy 7503 23 5 1 2 2 4 2 15 450 1 1.8 3.25
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